Observations placeholder
Kerlone
Identifier
019242
Type of Spiritual Experience
Background
A description of the experience
Betaxolol (trade names Betoptic, Betoptic S, Lokren, Kerlone) is a selective beta1 receptor blocker used in the treatment of hypertension and glaucoma. Theoretically, being selective for beta1 receptors, it is intended to have fewer systemic side effects than non-selective beta-blockers, for example, not causing bronchospasm (mediated by beta2 receptors) as others do.
In addition to its effect on the heart, betaxolol reduces the pressure within the eye (intraocular pressure). This effect is believed [sic] to be caused by reducing the production of the liquid (which is called the aqueous humor) within the eye. The precise mechanism of this effect is not known.
On Dec, 26, 2016 704 people reported to have side effects when taking Kerlone.
Among them, 5 people (0.71%) have Hallucination
On Dec, 10, 2015: 586 people reported to have side effects when taking Kerlone. Among them, 8 people (1.37%) have Death.
Time on Kerlone when people have Death :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Death | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |